Magnesium in PDB 4d09: PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
Enzymatic activity of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
All present enzymatic activity of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor:
3.1.4.17;
Protein crystallography data
The structure of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor, PDB code: 4d09
was solved by
P.Buijnsters,
J.I.Andres,
M.Deangelis,
X.Langlois,
F.Rombouts,
W.Sanderson,
G.Tresadern,
A.Trabanco,
G.Vanhoof,
Y.Vanroosbroeck,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.77 /
2.50
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
56.140,
73.430,
91.620,
109.37,
91.82,
91.05
|
R / Rfree (%)
|
20.642 /
27.746
|
Other elements in 4d09:
The structure of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
(pdb code 4d09). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the
PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor, PDB code: 4d09:
Jump to Magnesium binding site number:
1;
2;
3;
4;
Magnesium binding site 1 out
of 4 in 4d09
Go back to
Magnesium Binding Sites List in 4d09
Magnesium binding site 1 out
of 4 in the PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1002
b:11.5
occ:1.00
|
O
|
A:HOH2043
|
2.0
|
9.4
|
1.0
|
OD1
|
A:ASP697
|
2.1
|
14.3
|
1.0
|
O
|
A:HOH2042
|
2.1
|
25.5
|
1.0
|
O
|
A:HOH2034
|
2.2
|
17.0
|
1.0
|
O
|
A:HOH2054
|
2.3
|
9.8
|
1.0
|
O
|
A:HOH2044
|
2.3
|
7.1
|
1.0
|
CG
|
A:ASP697
|
3.1
|
15.3
|
1.0
|
OD2
|
A:ASP697
|
3.4
|
15.4
|
1.0
|
NE2
|
A:HIS730
|
3.9
|
19.3
|
1.0
|
ZN
|
A:ZN1001
|
3.9
|
26.5
|
1.0
|
CD2
|
A:HIS730
|
4.0
|
19.0
|
1.0
|
OE2
|
A:GLU727
|
4.1
|
19.3
|
1.0
|
OG1
|
A:THR768
|
4.1
|
16.9
|
1.0
|
O
|
A:HIS696
|
4.1
|
15.4
|
1.0
|
CD2
|
A:HIS696
|
4.2
|
15.7
|
1.0
|
O
|
A:HOH2033
|
4.4
|
18.1
|
1.0
|
CB
|
A:THR768
|
4.4
|
17.8
|
1.0
|
CB
|
A:ASP697
|
4.5
|
15.7
|
1.0
|
CD2
|
A:HIS700
|
4.5
|
19.6
|
1.0
|
NE2
|
A:HIS656
|
4.5
|
20.5
|
1.0
|
C28
|
A:7881
|
4.5
|
21.3
|
1.0
|
O
|
A:THR768
|
4.6
|
18.8
|
1.0
|
NE2
|
A:HIS700
|
4.6
|
19.8
|
1.0
|
CD2
|
A:HIS656
|
4.6
|
20.3
|
1.0
|
NE2
|
A:HIS696
|
4.6
|
15.6
|
1.0
|
CG
|
A:GLU727
|
4.7
|
18.7
|
1.0
|
OD2
|
A:ASP808
|
4.8
|
19.7
|
1.0
|
CD
|
A:GLU727
|
4.8
|
18.9
|
1.0
|
CA
|
A:ASP697
|
4.8
|
15.9
|
1.0
|
C27
|
A:7881
|
4.9
|
21.4
|
1.0
|
|
Magnesium binding site 2 out
of 4 in 4d09
Go back to
Magnesium Binding Sites List in 4d09
Magnesium binding site 2 out
of 4 in the PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg1002
b:14.3
occ:1.00
|
O
|
B:HOH2045
|
2.1
|
7.3
|
1.0
|
O
|
B:HOH2031
|
2.1
|
6.7
|
1.0
|
OD1
|
B:ASP697
|
2.2
|
18.6
|
1.0
|
O
|
B:HOH2029
|
2.2
|
5.7
|
1.0
|
O
|
B:HOH2032
|
2.3
|
13.1
|
1.0
|
CG
|
B:ASP697
|
3.2
|
18.5
|
1.0
|
OD2
|
B:ASP697
|
3.6
|
18.0
|
1.0
|
OG1
|
B:THR768
|
3.7
|
18.0
|
1.0
|
ZN
|
B:ZN1001
|
3.9
|
24.9
|
1.0
|
CD2
|
B:HIS696
|
3.9
|
20.7
|
1.0
|
OE2
|
B:GLU727
|
4.0
|
20.5
|
1.0
|
O
|
B:HIS696
|
4.1
|
21.4
|
1.0
|
NE2
|
B:HIS730
|
4.1
|
18.7
|
1.0
|
CD2
|
B:HIS730
|
4.1
|
19.1
|
1.0
|
CB
|
B:THR768
|
4.3
|
18.6
|
1.0
|
NE2
|
B:HIS696
|
4.3
|
20.8
|
1.0
|
O
|
B:THR768
|
4.4
|
20.7
|
1.0
|
CD2
|
B:HIS700
|
4.5
|
22.1
|
1.0
|
NE2
|
B:HIS700
|
4.5
|
22.4
|
1.0
|
CB
|
B:ASP697
|
4.5
|
18.6
|
1.0
|
OD2
|
B:ASP808
|
4.7
|
22.9
|
1.0
|
CG
|
B:GLU727
|
4.7
|
20.7
|
1.0
|
CA
|
B:ASP697
|
4.7
|
18.8
|
1.0
|
O
|
B:HOH2034
|
4.8
|
11.7
|
1.0
|
C28
|
B:7881
|
4.8
|
25.1
|
1.0
|
CD
|
B:GLU727
|
4.8
|
20.8
|
1.0
|
C
|
B:HIS696
|
4.9
|
19.9
|
1.0
|
C
|
B:THR768
|
4.9
|
20.2
|
1.0
|
|
Magnesium binding site 3 out
of 4 in 4d09
Go back to
Magnesium Binding Sites List in 4d09
Magnesium binding site 3 out
of 4 in the PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg1002
b:28.3
occ:1.00
|
O
|
C:HOH2010
|
2.4
|
16.5
|
1.0
|
O
|
C:HOH2009
|
2.8
|
10.4
|
1.0
|
C28
|
C:7881
|
3.1
|
25.0
|
1.0
|
NE2
|
C:HIS656
|
3.2
|
25.4
|
1.0
|
OD1
|
C:ASP697
|
3.2
|
21.8
|
1.0
|
NE2
|
C:HIS700
|
3.3
|
25.8
|
1.0
|
C29
|
C:7881
|
3.4
|
25.3
|
1.0
|
O
|
C:HOH2005
|
3.4
|
28.1
|
1.0
|
CD2
|
C:HIS656
|
3.7
|
25.7
|
1.0
|
C27
|
C:7881
|
4.0
|
25.1
|
1.0
|
CD2
|
C:HIS700
|
4.0
|
25.9
|
1.0
|
CE1
|
C:HIS656
|
4.0
|
24.7
|
1.0
|
CG
|
C:ASP697
|
4.1
|
22.3
|
1.0
|
OD2
|
C:ASP697
|
4.2
|
22.7
|
1.0
|
ZN
|
C:ZN1001
|
4.3
|
26.2
|
1.0
|
CE1
|
C:HIS700
|
4.3
|
25.8
|
1.0
|
O
|
C:HOH2008
|
4.3
|
13.6
|
1.0
|
C30
|
C:7881
|
4.3
|
25.8
|
1.0
|
OE2
|
C:GLU727
|
4.6
|
23.3
|
1.0
|
CG
|
C:HIS656
|
4.7
|
25.3
|
1.0
|
ND1
|
C:HIS656
|
4.8
|
24.5
|
1.0
|
C26
|
C:7881
|
4.8
|
25.2
|
1.0
|
C25
|
C:7881
|
5.0
|
25.5
|
1.0
|
|
Magnesium binding site 4 out
of 4 in 4d09
Go back to
Magnesium Binding Sites List in 4d09
Magnesium binding site 4 out
of 4 in the PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of PDE2A Catalytic Domain in Complex with A Brain Penetrant Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg1002
b:21.8
occ:1.00
|
O
|
D:HOH2032
|
2.2
|
11.6
|
1.0
|
O
|
D:HOH2023
|
2.4
|
21.7
|
1.0
|
OD1
|
D:ASP697
|
2.4
|
24.1
|
1.0
|
O
|
D:HOH2024
|
2.4
|
10.1
|
1.0
|
O
|
D:HOH2015
|
2.5
|
20.0
|
1.0
|
OE2
|
D:GLU727
|
3.1
|
24.5
|
1.0
|
NE2
|
D:HIS730
|
3.5
|
27.4
|
1.0
|
O
|
D:HOH2025
|
3.6
|
12.7
|
1.0
|
CG
|
D:ASP697
|
3.6
|
24.0
|
1.0
|
NE2
|
D:HIS700
|
3.7
|
27.0
|
1.0
|
CD2
|
D:HIS730
|
3.8
|
26.8
|
1.0
|
CD2
|
D:HIS700
|
3.9
|
27.6
|
1.0
|
CD
|
D:GLU727
|
4.1
|
24.6
|
1.0
|
OD2
|
D:ASP697
|
4.2
|
23.3
|
1.0
|
O
|
D:HIS696
|
4.3
|
23.9
|
1.0
|
OG1
|
D:THR768
|
4.4
|
22.3
|
1.0
|
CG
|
D:GLU727
|
4.4
|
25.0
|
1.0
|
ZN
|
D:ZN1001
|
4.7
|
28.0
|
1.0
|
C28
|
D:7881
|
4.7
|
25.8
|
1.0
|
CE1
|
D:HIS730
|
4.8
|
27.1
|
1.0
|
CB
|
D:ASP697
|
4.8
|
24.3
|
1.0
|
CB
|
D:THR768
|
4.8
|
23.6
|
1.0
|
CA
|
D:ASP697
|
4.9
|
24.6
|
1.0
|
O
|
D:HOH2016
|
5.0
|
21.9
|
1.0
|
O
|
D:THR768
|
5.0
|
24.7
|
1.0
|
|
Reference:
P.Buijnsters,
M.De Angelis,
X.Langlois,
F.J.R.Rombouts,
W.Sanderson,
G.Tresadern,
A.Ritchie,
A.A.Trabanco,
G.Vanhoof,
Y.V.Roosbroeck,
J.Andres.
Structure-Based Design of A Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement. Acs Med.Chem.Lett. V. 5 1049 2014.
ISSN: ISSN 1948-5875
PubMed: 25221665
DOI: 10.1021/ML500262U
Page generated: Thu Aug 15 16:58:13 2024
|